These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31537382)
1. Effects of vitamin D as a regulator of androgen intracrinology in LNCAP prostate cancer cells. Smith KW; Thompson PD; Rodriguez EP; Mackay L; Cobice DF Biochem Biophys Res Commun; 2019 Nov; 519(3):579-584. PubMed ID: 31537382 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor agonist EB1089 is a potent regulator of prostatic "intracrine" metabolism. Doherty D; Dvorkin SA; Rodriguez EP; Thompson PD Prostate; 2014 Feb; 74(3):273-85. PubMed ID: 24242708 [TBL] [Abstract][Full Text] [Related]
3. Spatial distribution of isobaric androgens in target tissues using chemical derivatization and MALDI-2 on a trapped ion mobility quadrupole time-of-flight instrument. Mackay CLL; Soltwisch J; Heijs B; Smith KW; Cruickshank FL; Nyhuis A; Dreisewerd K; Cobice D RSC Adv; 2021 Oct; 11(54):33916-33925. PubMed ID: 35497310 [TBL] [Abstract][Full Text] [Related]
4. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis. Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750 [TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms. Zhao XY; Peehl DM; Navone NM; Feldman D Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257 [TBL] [Abstract][Full Text] [Related]
7. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer. Nishiyama T; Hashimoto Y; Takahashi K Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082 [TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D in Prostate Cancer. Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
12. Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer. Suzuki K; Nishiyama T; Hara N; Yamana K; Takahashi K; Labrie F Prostate Cancer Prostatic Dis; 2007; 10(3):301-6. PubMed ID: 17387321 [TBL] [Abstract][Full Text] [Related]
14. Androgen metabolism in the human prostatic cancer cell line LNCaP. Negri-Cesi P; Motta M J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):89-96. PubMed ID: 7947355 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone. Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712 [TBL] [Abstract][Full Text] [Related]
17. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Labrie F; Bélanger A; Cusan L; Candas B J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308 [TBL] [Abstract][Full Text] [Related]
18. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line. Guillemette C; Hum DW; Bélanger A Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells. Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431 [TBL] [Abstract][Full Text] [Related]
20. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Murthy S; Agoulnik IU; Weigel NL Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]